美股市场个股详情
EMBC Embecta
- 14.250
- +0.170+1.21%
收盘价 11/01 16:00 (美东)
- 14.250
- 0.0000.00%
盘后 16:03 (美东)
8.22亿总市值11.88市盈率TTM
14.400最高价13.980最低价13.41万股成交量14.250今开14.080昨收189.94万成交额0.27%换手率11.68市盈率(静)5770.18万总股本19.15552周最高-1.08市净率7.18亿流通值9.70752周最低0.60股息TTM5037.19万流通股45.691历史最高4.21%股息率TTM2.98%振幅9.707历史最低14.165平均价1股每手
关于Embecta公司
Embecta Corp 是一家医疗技术公司。 该公司开发创新技术、服务和解决方案，帮助推进患者的临床治疗和医疗保健提供者的临床流程。 其产品包括 BD Pyxis、PureWick、Phasix 等。
公司介绍
公司代码EMBC
公司名称Embecta
上市日期2022/03/22
成立日期1924
CEOMr. Devdatt Kurdikar
所属市场纳斯达克
员工数量2200
年结日09-30
公司地址300 Kimball Drive,Suite 300
城市Parsippany
省份新泽西
国家美国
邮编07417-07054
电话1-862-401-0000
董事高管
- 姓名
- 职务
- 年薪
- Devdatt Kurdikar
- Director, President and Chief Executive Officer
- 746.45万
- Jacob Elguicze
- Interim Principal Accounting Officer, Senior Vice President and Chief Financial Officer
- 258.34万
- Colleen Riley
- Senior Vice President and Chief Technology Officer
- --
- Jean M. Casner
- Senior Vice President and Chief Human Resources Officer
- --
- Jeffrey Z. Mann
- Senior Vice President, General Counsel, Head of Corporate Development and Corporate Secretary
- 220.48万
- Slobodan Radumilo
- Senior Vice President and President, International
- --
- Ginny Blocki
- Senior Vice President, Product Management and Global Marketing
- --
- Tom Blount
- Senior Vice President and President, North America
- --
- Shaun Curtis
- Senior Vice President, Global Manufacturing and Supply Chain
- 149.04万
- General David F. Melcher
- Non-Executive Chairman of the Board
- 46.00万
- Carrie L. Anderson
- Independent Director
- 27.20万
- Christopher R. Reidy
- Independent Director
- 28.80万
- Robert J. Hombach
- Independent Director
- 28.80万
- Karen N. Prange
- Independent Director
- 28.80万
- David J. Albritton
- Independent Director
- 27.23万
- Dr. Claire Pomeroy, M.B.A.,M.D.
- Independent Director
- 29.30万
- Dr. Milton M. Morris,PhD
- Independent Director
- 27.70万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据